Defense World
04 Jan 2026, 06:55 UTC · 39w ago
Verdict
Headline takes no side. We score IRWD +0.90 across two claims — strongly bullish.
+0.90strongly bullish
More positive than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Search tags
What the story claims
2 claims · scored −1 bearish … +1 bullish
Zacks Research upgraded Ironwood Pharmaceuticals from a hold to a strong-buy rating.
More positive than 93% of claims this week
Ironwood Pharmaceuticals' stock price reached a new 52-week high of $5.78.
Continue reading
5 related stories
More positive than 65% of claims this week
Which stocks this story touches
More positive than 95% of ticker scores this week
The stock hit a 52-week high following a rating upgrade to 'strong-buy' by Zacks Research.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1h ago
−12.2%
Price is moving against the score
$3.75 vs $4.27 close before publication (Jan 2) · not market-adjusted
IRWD chart →
